(+)-schisandrin B multiple interactions ISO RGD:1305456 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TFCP2L1 mRNA] CTD PMID:31150632 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of TFCP2L1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of TFCP2L1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of TFCP2L1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of TFCP2L1 mRNA CTD PMID:17555576 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of TFCP2L1 mRNA CTD PMID:15598610 17beta-estradiol increases expression ISO RGD:1313494 6480464 Estradiol results in increased expression of TFCP2L1 mRNA CTD PMID:31614463 17beta-estradiol multiple interactions ISO RGD:1305456 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of TFCP2L1 mRNA CTD PMID:26496021 2,2',4,4'-Tetrabromodiphenyl ether affects expression EXP 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin affects the methylation of TFCP2L1 intron] which results in decreased expression of TFCP2L1 mRNA, [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of TFCP2L1 mRNA CTD PMID:17942748 , PMID:33017471 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1305456 6480464 Tetrachlorodibenzodioxin results in decreased expression of TFCP2L1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1305456 6480464 Tetrachlorodibenzodioxin results in increased expression of TFCP2L1 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of TFCP2L1 mRNA CTD PMID:26290441 2-hydroxypropanoic acid decreases expression ISO RGD:1313494 6480464 Lactic Acid results in decreased expression of TFCP2L1 mRNA CTD PMID:30851411 3,7-dihydropurine-6-thione decreases expression ISO RGD:1305456 6480464 Mercaptopurine results in decreased expression of TFCP2L1 mRNA CTD PMID:23358152 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of TFCP2L1 mRNA CTD PMID:28973697 5-fluorouracil increases expression EXP 6480464 Fluorouracil results in increased expression of TFCP2L1 protein CTD PMID:21296659 acetic acid decreases expression EXP 6480464 Acetic Acid results in decreased expression of TFCP2L1 protein CTD PMID:21296659 acrylamide increases expression ISO RGD:1305456 6480464 Acrylamide results in increased expression of TFCP2L1 mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO RGD:1305456 6480464 Aflatoxin B1 results in increased expression of TFCP2L1 mRNA CTD PMID:25378103 antirheumatic drug decreases expression ISO RGD:1313494 6480464 Antirheumatic Agents results in decreased expression of TFCP2L1 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:1313494 6480464 aristolochic acid I results in increased expression of TFCP2L1 mRNA CTD PMID:33212167 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of TFCP2L1 mRNA CTD PMID:25270620 benzo[a]pyrene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TFCP2L1 mRNA CTD PMID:27858113 benzo[a]pyrene affects methylation ISO RGD:1313494 6480464 Benzo(a)pyrene affects the methylation of TFCP2L1 intron CTD PMID:30157460 benzo[a]pyrene increases methylation ISO RGD:1313494 6480464 Benzo(a)pyrene results in increased methylation of TFCP2L1 3' UTR CTD PMID:27901495 benzo[b]fluoranthene decreases expression EXP 6480464 benzo(b)fluoranthene results in decreased expression of TFCP2L1 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TFCP2L1 mRNA CTD PMID:27858113 bisphenol A multiple interactions ISO RGD:1305456 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of TFCP2L1 mRNA CTD PMID:26496021 bisphenol A decreases methylation ISO RGD:1313494 6480464 bisphenol A results in decreased methylation of TFCP2L1 gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of TFCP2L1 mRNA CTD PMID:32156529 , PMID:35598803 bisphenol A affects methylation EXP 6480464 bisphenol A affects the methylation of TFCP2L1 promoter CTD PMID:27334623 bisphenol A affects expression ISO RGD:1305456 6480464 bisphenol A affects the expression of TFCP2L1 mRNA CTD PMID:25181051 butanal increases expression ISO RGD:1313494 6480464 butyraldehyde results in increased expression of TFCP2L1 mRNA CTD PMID:26079696 calcitriol increases expression ISO RGD:1313494 6480464 Calcitriol results in increased expression of TFCP2L1 mRNA CTD PMID:26485663 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1313494 6480464 CGP 52608 promotes the reaction [RORA protein binds to TFCP2L1 gene] CTD PMID:28238834 chlordecone increases expression EXP 6480464 Chlordecone results in increased expression of TFCP2L1 mRNA CTD PMID:33711761 chrysene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TFCP2L1 mRNA CTD PMID:27858113 ciguatoxin CTX1B affects expression EXP 6480464 Ciguatoxins affects the expression of TFCP2L1 mRNA CTD PMID:18353800 cobalt dichloride increases expression ISO RGD:1305456 6480464 cobaltous chloride results in increased expression of TFCP2L1 mRNA CTD PMID:24386269 copper(II) sulfate decreases expression ISO RGD:1313494 6480464 Copper Sulfate results in decreased expression of TFCP2L1 mRNA CTD PMID:19549813 deoxynivalenol decreases expression ISO RGD:1313494 6480464 deoxynivalenol results in decreased expression of TFCP2L1 protein CTD PMID:33890134 dibenz[a,h]anthracene decreases expression EXP 6480464 1 more ... CTD PMID:26377693 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of TFCP2L1 mRNA CTD PMID:17394237 dimethylarsinous acid decreases expression ISO RGD:1313494 6480464 dimethylarsinous acid results in decreased expression of TFCP2L1 mRNA CTD PMID:23876855 dorsomorphin multiple interactions ISO RGD:1313494 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan decreases expression ISO RGD:1305456 6480464 Endosulfan results in decreased expression of TFCP2L1 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1313494 6480464 entinostat results in increased expression of TFCP2L1 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1313494 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFCP2L1 mRNA CTD PMID:27188386 ethanol increases expression ISO RGD:1313494 6480464 Ethanol results in increased expression of TFCP2L1 mRNA CTD PMID:28986285 ethanol affects expression EXP 6480464 Ethanol affects the expression of TFCP2L1 mRNA CTD PMID:30319688 ethanol increases expression EXP 6480464 Ethanol results in increased expression of TFCP2L1 mRNA CTD PMID:30319688 fenthion decreases expression EXP 6480464 Fenthion results in decreased expression of TFCP2L1 mRNA CTD PMID:34813904 furan increases expression ISO RGD:1305456 6480464 furan results in increased expression of TFCP2L1 mRNA CTD PMID:25539665 lead diacetate increases expression ISO RGD:1305456 6480464 lead acetate results in increased expression of TFCP2L1 mRNA CTD PMID:22641619 mercaptopurine decreases expression ISO RGD:1305456 6480464 Mercaptopurine results in decreased expression of TFCP2L1 mRNA CTD PMID:23358152 methylmercury chloride increases expression ISO RGD:1313494 6480464 methylmercuric chloride results in increased expression of TFCP2L1 mRNA CTD PMID:23903816 N-ethyl-N-nitrosourea increases mutagenesis EXP 6480464 Ethylnitrosourea results in increased mutagenesis of TFCP2L1 intron CTD PMID:27776689 nickel atom decreases expression ISO RGD:1313494 6480464 Nickel results in decreased expression of TFCP2L1 mRNA CTD PMID:24768652 , PMID:25583101 okadaic acid increases expression EXP 6480464 Okadaic Acid results in increased expression of TFCP2L1 mRNA CTD PMID:25270620 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of TFCP2L1 mRNA CTD PMID:34911549 panobinostat multiple interactions ISO RGD:1313494 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFCP2L1 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1313494 6480464 panobinostat results in increased expression of TFCP2L1 mRNA CTD PMID:26272509 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of TFCP2L1 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1305456 6480464 Acetaminophen results in increased expression of TFCP2L1 mRNA CTD PMID:33387578 phenobarbital multiple interactions EXP 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of TFCP2L1 mRNA] CTD PMID:19482888 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of TFCP2L1 mRNA CTD PMID:23091169 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of TFCP2L1 mRNA CTD PMID:19270015 , PMID:19482888 PhIP decreases expression ISO RGD:1305456 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in decreased expression of TFCP2L1 mRNA CTD PMID:15215175 progesterone affects expression EXP 6480464 Progesterone affects the expression of TFCP2L1 mRNA CTD PMID:17251523 progesterone decreases expression ISO RGD:1313494 6480464 Progesterone results in decreased expression of TFCP2L1 mRNA CTD PMID:21540246 propanal increases expression ISO RGD:1313494 6480464 propionaldehyde results in increased expression of TFCP2L1 mRNA CTD PMID:26079696 purine-6-thiol decreases expression ISO RGD:1305456 6480464 Mercaptopurine results in decreased expression of TFCP2L1 mRNA CTD PMID:23358152 rac-lactic acid decreases expression ISO RGD:1313494 6480464 Lactic Acid results in decreased expression of TFCP2L1 mRNA CTD PMID:30851411 rotenone increases expression EXP 6480464 Rotenone results in increased expression of TFCP2L1 mRNA CTD PMID:32937126 SB 431542 multiple interactions ISO RGD:1313494 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1313494 6480464 Silicon Dioxide analog results in decreased expression of TFCP2L1 mRNA, Silicon Dioxide results in decreased expression of TFCP2L1 mRNA CTD PMID:25351596 , PMID:25895662 sodium arsenite increases expression ISO RGD:1313494 6480464 sodium arsenite results in increased expression of TFCP2L1 mRNA CTD PMID:34032870 tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of TFCP2L1 mRNA CTD PMID:25123088 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of TFCP2L1 mRNA CTD PMID:17555576 testosterone increases expression EXP 6480464 Testosterone results in increased expression of TFCP2L1 mRNA CTD PMID:20403060 tetrachloromethane increases expression ISO RGD:1305456 6480464 Carbon Tetrachloride results in increased expression of TFCP2L1 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions ISO RGD:1305456 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TFCP2L1 mRNA] CTD PMID:31150632 tetraphene decreases expression EXP 6480464 benz(a)anthracene results in decreased expression of TFCP2L1 mRNA CTD PMID:26377693 tetraphene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TFCP2L1 mRNA CTD PMID:27858113 thioacetamide increases expression ISO RGD:1305456 6480464 Thioacetamide results in increased expression of TFCP2L1 mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of TFCP2L1 mRNA CTD PMID:23557971 trichostatin A increases expression ISO RGD:1313494 6480464 trichostatin A results in increased expression of TFCP2L1 mRNA CTD PMID:24935251 triptonide increases expression EXP 6480464 triptonide results in increased expression of TFCP2L1 mRNA CTD PMID:33045310 urethane decreases expression ISO RGD:1313494 6480464 Urethane results in decreased expression of TFCP2L1 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1313494 6480464 Valproic Acid affects the expression of TFCP2L1 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:1313494 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFCP2L1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1313494 6480464 Valproic Acid results in increased expression of TFCP2L1 mRNA CTD PMID:26272509 , PMID:28001369 vinclozolin decreases expression ISO RGD:1305456 6480464 vinclozolin results in decreased expression of TFCP2L1 mRNA CTD PMID:20566332 vinclozolin affects expression ISO RGD:1305456 6480464 vinclozolin affects the expression of TFCP2L1 mRNA CTD PMID:23034163 zoledronic acid decreases expression ISO RGD:1313494 6480464 zoledronic acid results in decreased expression of TFCP2L1 mRNA CTD PMID:24714768